E. A. Eisenhauer
121 works · 34,136 citations · h-index 33
Top works
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
- RECIST revisited: A review of validation studies on tumour assessment
- Evaluation of lymph nodes with RECIST 1.1
- Lessons learned from independent central review
- 2004 consensus statements on the management of ovarian cancer: final document of the 3rd International Gynecologic Cancer Intergroup Ovarian Cancer Consensus Conference (GCIG OCCC 2004)
- Advanced epithelial ovarian cancer: 1993 consensus statements
- Gemcitabine is an active new agent in previously untreated extensive small cell lung cancer (SCLC)
- Predictors of response to subsequent chemotherapy in platinum pretreated ovarian cancer: A multivariate analysis of 704 patients
- Successful re-treatment with taxol after major hypersensitivity reactions.
- Carboplatin versus cisplatin
- Clinical prognostic factors affecting survival in patients with newly diagnosed Glioblastoma Multiforme (GBM)
- Speeding up the Evaluation of New Agents in Cancer
- A new frontier for quality of care in gynecologic oncology surgery: Multi-institutional assessment of short-term outcomes for ovarian cancer using a risk-adjusted model
- Advanced epithelial ovarian cancer: 1998 consensus statements
- Clinical trials in ovarian carcinoma: study methodology
- Phase I trial design: Are new methodologies being put into practice?
- Long-term follow-up of patients with advanced ovarian carcinoma treated with chemotherapy
- Real-world evidence in the treatment of ovarian cancer
- Gemcitabine/carboplatin (GC) vs. carboplatin (C) in platinum sensitive recurrent ovarian cancer (OVCA). Results of a Gynecologic Cancer Intergroup randomized phase III trial of the AGO OVAR, the NCIC CTG and the EORTC GCG
- Phase II study of carboplatin in patients with ovarian carcinoma: a National Cancer Institute of Canada Clinical Trials Group Study.